|
Volumn 1218, Issue 2, 2011, Pages 229-236
|
Magnetic beads method for determination of binding of drugs to melanin
|
Author keywords
Affinity chromatography; Drug binding; Extrapyramidal symptoms; Magnetic beads; Magnetic nanoparticles; Quantitative structure property relationships
|
Indexed keywords
DRUG-BINDING;
EXTRAPYRAMIDAL SYMPTOMS;
MAGNETIC BEADS;
MAGNETIC NANOPARTICLES;
QUANTITATIVE STRUCTURE PROPERTY RELATIONSHIPS;
AFFINITY CHROMATOGRAPHY;
DRUG PRODUCTS;
NANOPARTICLES;
SUPERPARAMAGNETISM;
NANOMAGNETICS;
CHLORPROMAZINE;
CLOZAPINE;
DIPHENHYDRAMINE;
FLUPHENAZINE;
HALOPERIDOL;
IMIPRAMINE;
LEVODOPA;
MAGNETIC BEAD;
MAGNETIC NANOPARTICLE;
MELANIN;
MELATONIN;
NEUROLEPTIC AGENT;
NICOTINE;
PROFENAMINE;
PROMAZINE;
QUININE;
SELEGILINE;
THIORIDAZINE;
TRIFLUOPERAZINE;
TRIFLUPROMAZINE;
UNCLASSIFIED DRUG;
VENLAFAXINE;
ZIPRASIDONE;
ARTICLE;
BINDING AFFINITY;
CALCULATION;
CHEMICAL REACTION;
DRUG BINDING;
DRUG STRUCTURE;
EXTRAPYRAMIDAL SYMPTOM;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
IMMOBILIZATION;
PRIORITY JOURNAL;
QUANTITATIVE STRUCTURE PROPERTY RELATION;
ANTIPSYCHOTIC AGENTS;
CHEMISTRY, PHARMACEUTICAL;
CHROMATOGRAPHY, AFFINITY;
DRUG INTERACTIONS;
LINEAR MODELS;
MAGNETITE NANOPARTICLES;
MELANINS;
QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 78650566549
PISSN: 00219673
EISSN: None
Source Type: Journal
DOI: 10.1016/j.chroma.2010.11.015 Document Type: Article |
Times cited : (24)
|
References (31)
|